Blocking NR2B subunits not only prevents hyperexcitation caused by Abeta but also rescues Abeta induced LTP impairment [22, 48], suggesting that blocking NR2B subunits might be a promising target in AD. This evidence concerns the gene GRIN2B and Alzheimer disease.